(Q43807426)

English

Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway

scientific article published in December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Morgan WW

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Nelson JF

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

921

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

115-121

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Melatonin stimulates brain glutathione peroxidase activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Melatonin reduces nitric oxide synthase activity in rat hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Melatonin reduces oxidative neurotoxicity due to quinolinic acid:

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Melatonin protects against lipid peroxidation induced by delta-aminolevulinic acid in rat cerebellum, cortex and hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Melatonin attenuates neuronal NADPH-d/NOS expression in the hypoglossal nucleus of adult rats following peripheral nerve injury

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces dopamine and serotonin but accelerates norepinephrine metabolism in the rat brain. Effect of chronic pretreatment with MPTP

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-D-aspartate excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Radioimmunoassay of melatonin in rat serum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Melatonin suppresses iron-induced neurodegeneration in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

The effect of long-term dietary supplementation with antioxidants.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Effect of immobilization stress on serotonin content and turnover in regions of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Pineal control of aging: effect of melatonin and pineal grafting on aging mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Use of liquid chromatography with electrochemistry to measure effects of varying intensities of white light on DOPA accumulation in rat retinas

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Acute effects of a parkinsonism-inducing neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mouse body temperature

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Melatonin protects hippocampal neurons in vivo against kainic acid-induced damage in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Melatonin reduces the increase in 8-hydroxy-deoxyguanosine levels in the brain and liver of kainic acid-treated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Demonstration of rapid light-induced advances and delays of the human circadian clock using hormonal phase markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of long-term administration of melatonin and a putative antagonist on the ageing rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903106-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-8993(01)03106-7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43807426&oldid=2103512519"